ORKA
Oruka Therapeutics Inc.

211
Mkt Cap
$1.67B
Volume
412,108.00
52W High
$36.53
52W Low
$5.49
PE Ratio
-14.24
ORKA Fundamentals
Price
$34.41
Prev Close
$34.32
Open
$34.20
50D MA
$32.05
Beta
1.06
Avg. Volume
522,044.80
EPS (Annual)
-$4.99
P/B
3.44
Rev/Employee
$0.00
$46.20
Loading...
Loading...
News
all
press releases
Oruka Therapeutics (NASDAQ:ORKA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Oruka Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday
Oruka Therapeutics (NASDAQ:ORKA) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 52-Week High - What's Next?
Oruka Therapeutics (NASDAQ:ORKA) Hits New 52-Week High - Here's Why...
MarketBeat·4d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Moderate Buy" from Brokerages
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has received an average rating of "Moderate Buy" from the nine research firms that are presently covering the company, MarketBeat.com reports...
MarketBeat·5d ago
News Placeholder
Insider Selling: Oruka Therapeutics (NASDAQ:ORKA) Insider Sells 7,000 Shares of Stock
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) insider Joana Goncalves sold 7,000 shares of the business's stock in a transaction dated Tuesday, February 17th. The shares were sold at an...
MarketBeat·12d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Insider Joana Goncalves Sells 7,000 Shares
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) insider Joana Goncalves sold 7,000 shares of the firm's stock in a transaction dated Tuesday, February 17th. The shares were sold at an...
MarketBeat·12d ago
News Placeholder
Candriam S.C.A. Buys 250,296 Shares of Oruka Therapeutics, Inc. $ORKA
Candriam S.C.A. raised its stake in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 214.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·19d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 31.3% in January
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totaling 5,241,278...
MarketBeat·29d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of "Moderate Buy" by Analysts
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the ten analysts that are covering the stock, MarketBeat.com...
MarketBeat·30d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap Down - Here's What Happened
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap Down - Here's What Happened...
MarketBeat·1mo ago
<
1
2
...
>

Latest ORKA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.